Lista de obras -

Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes

article

Aspirin in patients undergoing noncardiac surgery

artículo científico publicado en 2014

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

artículo científico publicado en 2002

Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

artículo científico publicado en 2015

Clonidine in patients undergoing noncardiac surgery

artículo científico

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

artículo científico publicado en 2006

Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy

artículo científico publicado en 2008

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndrom

artículo científico publicado en 2005

Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes

artículo científico publicado en 2011

Differences in the management and prognosis of women and men who suffer from acute coronary syndromes

artículo científico publicado en 2005

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes ⬇️

artículo científico publicado el 2 de septiembre de 2010

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial ⬇️

artículo científico publicado el 9 de octubre de 2010

Dronedarone in High-Risk Permanent Atrial Fibrillation

artículo científico publicado en 2011

Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials

artículo científico publicado en 2009

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

article

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

artículo científico publicado en 2009

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

artículo científico publicado en 2008

Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment

artículo científico publicado en 2007

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

artículo científico

Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year

artículo científico publicado en 2013

Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial

artículo científico publicado en 2010

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes

artículo científico publicado en 2009

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

artículo científico publicado en 2007

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

artículo científico publicado en 2015

Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk

artículo científico publicado en 2009

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevat

artículo científico publicado en 2010

Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

artículo científico publicado en 2007

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2008

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes

scientific article published on 01 September 2007

Irbesartan in Patients with Atrial Fibrillation ⬇️

artículo científico publicado el 10 de marzo de 2011

Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial

artículo científico

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W.

artículo científico publicado en 2010

Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 Days ⬇️

artículo científico publicado el 26 de marzo de 2012

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial ⬇️

artículo científico publicado el 4 de abril de 2011

Rationale and design of The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study: A large international randomized trial in cardiac surgery

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes

artículo científico publicado en 2009

The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study

artículo científico publicado en 2004

The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial

artículo científico publicado en 2008

Lista de obras de

Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes

Aspirin in patients undergoing noncardiac surgery

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

Clonidine in patients undergoing noncardiac surgery

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndrom

Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes

Differences in the management and prognosis of women and men who suffer from acute coronary syndromes

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes ⬇️

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial ⬇️

Dronedarone in High-Risk Permanent Atrial Fibrillation

Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year

Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevat

Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes

Irbesartan in Patients with Atrial Fibrillation ⬇️

Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W.

Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 Days ⬇️

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial ⬇️

Rationale and design of The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study: A large international randomized trial in cardiac surgery

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes

The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study

The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial